Presentation ACC 2019 Primary Results From the Evolut Low Risk Trial Presenter: Michael J. Reardon March 17, 2019 REGISTER for free or LOG IN to view this content Structural Heart Aortic Valve Presentation ACC 2019 Evolut R SAVR TAVR Michael J. Reardon Up Next Presentation ACC 2019 Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial Presenter: Federico M. Asch March 17, 2019 More slides + Presentation ACC 2019 Blinded Physiological Assessment of Residual Ischemia after Successful Angiographic PCI Presenter: Allen Jeremias March 18, 2019 Presentation ACC 2019 Impact of FFRCT on 1-Year Outcomes: Lessons from the ADVANCE Registry Presenter: Manesh Patel March 18, 2019 We Recommend
Presentation ACC 2019 Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial Presenter: Federico M. Asch March 17, 2019
Presentation ACC 2019 Blinded Physiological Assessment of Residual Ischemia after Successful Angiographic PCI Presenter: Allen Jeremias March 18, 2019
Presentation ACC 2019 Impact of FFRCT on 1-Year Outcomes: Lessons from the ADVANCE Registry Presenter: Manesh Patel March 18, 2019